Grant to study how cells sense electric fields
Do amoebae dream of electric sheep?
Learning how living cells can detect and respond to electric fields is the aim of a $570,000, three-year grant from the National Science Foundation to Min Zhao, professor of dermatology and ophthalmology at the UC Davis Health System and Center for neuroscience.
Living cells are already known to respond to electric fields, as well as being able to sense light, temperature and chemical signals. Understanding this mechanism would establish a new biological signaling mechanism, with implications for engineering tissues and wound healing as well as in basic science, Zhao said.
Zhao and colleagues will use the grant to generate hundreds of thousands of genetic mutations in the amoeba Dictyostelium discoideum. They will collaborate with Tingrui Pan, professor of biomedical engineering, to develop methods to quickly screen thousands of mutant amoebae for those that do not respond to electric fields. Those defective amoebae will allow the scientists to home in on the genes and molecules responsible.
Dictyostelium was selected for the study because it is the simplest cell to work with that also moves, Zhao said.
In previous work, Zhao and his collaborators found that wounds generate a weak electric field that guides cells moving in to repair the wound.
"The big question is, how do the cells detect the electric field?" Zhao said. He believes that there is a molecule or set of molecules within cells that respond to electric fields.
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals

Reclaiming the immune system's assault on tumors
Biotage AB and McMaster University sign joint agreement to develop new chemistry platform

Captain T Cell secures seed financing round - Start-up develops first-in-class efficacy-enhanced TCR-T cells for solid tumors that are not addressed by existing therapies

Gut bacteria affect ageing

Obulytix is developing a revolutionary solution for antibiotic resistance - Spin-off has built a platform that creates new ways to tackle bacterial infections
XOMA Licenses BCE Technology for Recombinant Protein Production to Wyeth
Light activated 'warhead' turns modest molecules into super protein killers - Novel research tool from Scripps Florida could significantly expand search for new therapies

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland - “The investment in Cork is the biggest site investment in the history of our Life Science business”
Rondaxe and TD2 form strategic drug development alliance

Soft millirobots for minimally invasive surgery and drug delivery?
